γ-PGA Industrial Grade

Shandong Freda Pharmaceutical Group Co., Ltd. was established in 1993. After more than 20 years of development and growth, it has grown into a health industry group integrating science, industry and trade. Freda Pharmaceutical Group relies on two provincial scientific research institutes, Shandong Provincial Institute of Pharmaceutical Sciences and Shandong Provincial Pharmaceutical Industry Design Institute, using its own intellectual property to form Shandong Baoshilun Freda Pharmaceutical Co., Ltd. and Shandong Mingren Freda Pharmaceutical Co., Ltd. Co., Ltd., Shandong Freda Biological Engineering Co., Ltd., Shandong Freda Biological Technology Co., Ltd. and other high-tech enterprises, have a national enterprise technology center, an academician workstation and a provincial key laboratory and 7 A provincial enterprise technology center / engineering technology research center. The industry involved involves medicines, health products, foods, cosmetics, medical devices, raw materials, etc., and has many products such as "Runshu", "Runjie", "Sprite", "Akihito", "Yilian", "Yueji", etc. Well-known brands.

Shandong Provincial College of Pharmaceutical Sciences is the strongest pharmaceutical R & D institution in Shandong Province. It has 5 national-level platforms including the National Comprehensive New Drug Research and Development Platform. It has won three second prizes of National Science and Technology Progress Award and applied for nearly 200 invention patents. Shandong Baoshilun Furui Da Pharmaceutical Co., Ltd. is a well-known domestic ophthalmic medicine manufacturer, which has formed the research and production capacity of ophthalmic medicine, surgical medicine, dermatology medicine and internal medicine medicine series. Shandong Mingren Freda Pharmaceutical Co., Ltd. is a modern Chinese medicine manufacturer with products covering orthopedics, gynecology, internal medicine, ophthalmology, and pediatrics. It has been listed as a demonstration project of biomedicine high-tech industrialization by the National Development and Reform Commission. Shandong Freda Bioengineering Co., Ltd. has been adhering to the corporate vision of "technological wisdom to create skin ecological aesthetics", and has become the most powerful cosmetic production enterprise in Shandong Province with research and development and production strength. In recent years, Freda Pharmaceutical Group has invested in Freda Biotechnology and other high-tech enterprises around the health, and established a full range of hospitals, grassroots medical institutions, chain pharmacies and third terminals in the country Terminal network and sales channels are distributed in 30 provinces and cities.

In the future, FredaPharmaceutical Group will seize the opportunity of capital operation and the implementation of major projects for the conversion of old and new kinetic energy, focus on high-end generic drugs, modern Chinese medicine, innovative medicines and biotechnology cosmetics, and vigorously implement "innovation-driven, talent-led, brand-driven" Great strategy, strive to achieve asset-light, intelligent, capitalized, cooperative, and technological development; focus on building the leading brand of orthopedic medicine and cosmetics in China, make the most important ophthalmic medicine production base in the country, and fully promote the innovation and development of the Chinese pharmaceutical industry To make new contributions to the cause of human health.